Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewan Pearson

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Nature Genetics|March 30, 2012
The role of ATM in response to metformin treatment and activation of AMPKKaixin Zhou, Celine Bellenguez, Calum Sutherland, et al.
Informatics in Primary Care|May 1, 2010
Desktop software to identify patients eligible for recruitment into a clinical trial: using SARMA to recruit to the ROAD feasibility trialShaun Treweek, Ewan Pearson, Natalie Smith, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 16, 2026
Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity-score matched analysisHaolan Tu, Chengsheng Ju, Stuart J McGurnaghan, et al.
Drug Discovery Today|November 8, 2016
Defining drug response for stratified medicineMike Lonergan, Stephen J Senn, Christine McNamee, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) studyAlex S F Doney, Jennifer Dannfald, Charlotte H Kimber, et al.
BMJ Open|March 21, 2020
Strategies to identify individuals with monogenic diabetes: results of an economic evaluationJaime L Peters, Rob Anderson, Beverley Shields, et al.
BMJ Open|September 28, 2019
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 yearsAnita Lynam, Timothy McDonald, Anita Hill, et al.
BMJ Open|October 5, 2025
Study protocol for an open-label, single-arm, mixed methods feasibility study of the MWIQ AI-powered decision support tool for diabetes management in GP practicesJane Dickson, Scott G Cunningham, Chris Sainsbury, et al.
BMJ Open|December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocolCatherine Angwin, Caroline Jenkinson, Angus Jones, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 29, 2018
Sharing data for future research-engaging participants' views about data governance beyond the original project: a DIRECT StudyNisha Shah, Victoria Coathup, Harriet Teare, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Nature Genetics|March 30, 2012
The role of ATM in response to metformin treatment and activation of AMPKKaixin Zhou, Celine Bellenguez, Calum Sutherland, et al.
Informatics in Primary Care|May 1, 2010
Desktop software to identify patients eligible for recruitment into a clinical trial: using SARMA to recruit to the ROAD feasibility trialShaun Treweek, Ewan Pearson, Natalie Smith, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 16, 2026
Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity-score matched analysisHaolan Tu, Chengsheng Ju, Stuart J McGurnaghan, et al.
Drug Discovery Today|November 8, 2016
Defining drug response for stratified medicineMike Lonergan, Stephen J Senn, Christine McNamee, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) studyAlex S F Doney, Jennifer Dannfald, Charlotte H Kimber, et al.
BMJ Open|March 21, 2020
Strategies to identify individuals with monogenic diabetes: results of an economic evaluationJaime L Peters, Rob Anderson, Beverley Shields, et al.
BMJ Open|September 28, 2019
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 yearsAnita Lynam, Timothy McDonald, Anita Hill, et al.
BMJ Open|October 5, 2025
Study protocol for an open-label, single-arm, mixed methods feasibility study of the MWIQ AI-powered decision support tool for diabetes management in GP practicesJane Dickson, Scott G Cunningham, Chris Sainsbury, et al.
BMJ Open|December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocolCatherine Angwin, Caroline Jenkinson, Angus Jones, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 29, 2018
Sharing data for future research-engaging participants' views about data governance beyond the original project: a DIRECT StudyNisha Shah, Victoria Coathup, Harriet Teare, et al.
Pageof 5